Literature DB >> 7213535

Clinical pharmacology of prazosin: further discussion.

C Barbieri, R Caldara, C Ferrari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7213535      PMCID： PMC1401611          DOI： 10.1111/j.1365-2125.1981.tb00544.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Effects of prazosin in patients with hypertension.

Authors:  P Bolli; A J Wood; F O Simpson
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

2.  Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

Review 3.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

Review 4.  Role of brain monoamines and histamine in regulation of anterior pituitary secretion.

Authors:  R I Weiner; W F Ganong
Journal:  Physiol Rev       Date:  1978-10       Impact factor: 37.312

5.  Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Authors:  A J Wood; P Bolli; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 6.  Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

7.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

8.  Physiologic evaluation of a new antihypertensive agent: prazosin HCl.

Authors:  M C Koshy; D Mickley; J Bourgiognie; M D Blaufox
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

9.  Metabolic effects of prazosin.

Authors:  C Barbieri; R Caldara; C Ferrari; G A Dal Bo; A Paracchi; M Romussi; G Curtarelli
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

10.  Metabolic effects of chronic prazosin treatment.

Authors:  C Barbieri; C Ferrari; M Borzio; V Piepoli; R Caldara
Journal:  Horm Metab Res       Date:  1980-07       Impact factor: 2.936
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.